Global Vaccine Market by Technology (Inactivated, Subunit, Conjugate, Live Attenuated, Toxoid, and Dendritic Cell Synthetic), Type (Therapeutic, Preventive), Indication (Allergy, Infectious Disease, Tumors and Others) for Infants, Early Aged, and Post Aged: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2014 – 2020

Global Vaccine Market: Study provides historic data of 2014 along with a forecast from 2015 to 2020 based revenue (USD Million)


The report covers forecast and analysis for the vaccine market on a global and regional level. According to the report, global demand for vaccine was valued at over USD 32.2 billion in 2014, is expected to reach above USD 59.2 billion in 2020 and is anticipated to grow at a CAGR of slightly above 11.0% between 2015 and 2020.The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes study of opportunities available in the vaccine market on a global level.

Introduction of new vaccines for various diseases is escalating growth of the vaccine market. Also rise in frequency of diverse infectious diseases such as swine flu, influenza, Ebola, hepatitis, tuberculosis, diphtheria, meningococcal diseases, and pneumococcal diseases worldwide has increased the use of vaccines. Besides, the notable rise demand of the existing vaccines is predicted to enhance the growth of market. Government initiative to generate awareness among people for vaccination is also supporting the market growth. However, high maintenance, strict laws of regulatory and huge expense for development of new vaccines could pose challenge for the vaccine market. Government funding for R&D of new vaccines for diseases like HIV and cancer offers novel opportunity for vaccine market.

In order to give the users of this report a comprehensive view on the vaccine market, we have included a detailed competitive scenario, and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the vaccine market has also been included. The study encompasses a market attractiveness analysis, wherein technology segments are benchmarked based on their market size, growth rate and general attractiveness.

Technological advancement in use of vaccine includes inactivated, subunit, conjugate, live attenuated, toxoid, dendritic cell and synthetic. Live attenuated is the recommended technology and accepted worldwide followed by inactivated technology. Two types of vaccine are therapeutic vaccine and preventive vaccine. Preventive vaccine was the leading type due to escalating awareness among people for prevention from various infections.

End users for the ingestion or injection of vaccine are infants, early aged and post aged group. Infants and early aged populace are vaccinated on large basis due to government initiative for protecting children from various diseases. The indication segment for vaccine includes allergy, infectious disease, and tumors among others. Infectious disease was one of the major indications due to increase in number of infectious and contiguous diseases globally.

North America emerged as prominent regional market owing to rising government support for R&D of vaccines, growing company investments for vaccine research, and high occurrence of different diseases in this region. The vaccine market is segment into Europe, Asia-Pacific, Latin America, and Middle East & Africa, further divergence of region on the country level, which includes U.S., Germany, UK, France, China, Japan and India.

The study provides a decisive view on the vaccine market by segmenting the market based on technology, type, end-users, indication and region. Inactivated, subunit, conjugate, live attenuated, toxoid, dendritic cell and synthetic are the technological segments of the vaccine market. Preventive and therapeutic are the two types of vaccine. All the segments have been analyzed based on present and future trends and the market is estimated from 2014 to 2020. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil.

The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. Key players profiled in the report include Pfizer, CSL Limited, GlaxoSmithKline, plc, MedImmune, LLC, Novartis AG, Sanofi Pasteur, Merck and Company, Johnson and Johnson and Emergent BioSolutions Inc among others.

This report segments the vaccine market as follows:

Vaccine Market: Technology Segment Analysis

  • Inactivated
  • Subunit
  • Conjugate
  • Live Attenuated
  • Toxoid
  • Dendritic Cell
  • Synthetic

Vaccine Market: Type Segment Analysis

  • Therapeutic vaccine
  • Preventive vaccine

Vaccine Market: End user Segment Analysis

  • Infants
  • Early aged
  • Post aged

Vaccine Market: Indications Segment Analysis

  • Allergy
  • Infectious disease
  • Tumors
  • Others

Vaccine Market: Regional Segment Analysis

  • North America
    • US
  • Europe
    • Germany
    • France
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Chapter 1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
Chapter 2. Executive Summary
2.1. Global market revenue, 2014 – 2020(USD Million)
2.2. Global vaccine market: Snapshot
Chapter 3. Vaccine Market – Global and Industry Analysis
3.1. Vaccine : Market dynamics
3.2. Market drivers
3.2.1. Drivers of global vaccine market: Impact analysis
3.2.2. Rise in frequency of diseases worldwide
3.2.3. Introduction of new vaccines
3.3. Market restraints
3.3.1. Restraints of global vaccine market: Impact analysis
3.3.2. High maintenance for preservation of vaccines
3.3.3. Strict laws of regulatory for production of vaccine
3.3.4. Huge expense for R&D of vaccines
3.4. Opportunities
3.4.1. Increasing demand from developing countries
3.4.2. Government initiatives
3.4.3. Development of new vaccines
3.5. Porter’s five forces analysis
3.6. Market Attractiveness Analysis
3.6.1. Market attractiveness analysis by technology segment
3.6.2. Market attractiveness analysis by type segment
3.6.3. Market attractiveness analysis by end user segment
3.6.4. Market attractiveness analysis by indication segment
3.6.5. Market attractiveness analysis by regional segment
Chapter 4. Global Vaccine Market – Competitive Landscape
4.1. Company market share, 2014
4.2. Price trend analysis
Chapter 5. Global Vaccine Market – Technology Segment Analysis
5.1. Global vaccine market: technology overview
5.1.1. Global vaccine market revenue share, by technology, 2014 – 2020
5.2. Inactivated vaccines
5.2.1. Global inactivated vaccines market, by technology, 2014 – 2020 (USD Million)
5.3. Subunit vaccines
5.3.1. Global subunit vaccines market, by technology, 2014 – 2020 (USD Million)
5.4. Conjugate vaccines
5.4.1. Global conjugate vaccines market, by technology, 2014 – 2020 (USD Million)
5.5. Live attenuated vaccines
5.5.1. Global live attenuated vaccines market, by technology, 2014 – 2020 (USD Million)
5.6. Toxoid vaccines
5.6.1. Global toxoid vaccines market, by technology, 2014 – 2020 (USD Million)
5.7. Others (dendritic cell vaccines, synthetic vaccines)
5.7.1. Global others vaccines market, by technology, 2014 – 2020 (USD Million)
Chapter 6. Global Vaccine Market – Type Segment Analysis
6.1. Global vaccine market: type overview
6.1.1. Global vaccine market revenue share, by type, 2014 – 2020
6.2. Therapeutic vaccines
6.2.1. Global therapeutic vaccines market, by type, 2014 – 2020 (USD Million)
6.3. Preventive vaccines
6.3.1. Global preventive vaccines market, by type, 2014 – 2020 (USD Million)
Chapter 7. Global Vaccine Market – End users Segment Analysis
7.1. Global vaccine market: type overview
7.1.1. Global vaccine market revenue share, by end users, 2014 – 2020
7.2. Infants
7.2.1. Global infants market, by type, 2014 – 2020 (USD Million)
7.3. Early aged
7.3.1. Global early aged market, by end users, 2014 – 2020 (USD Million)
7.4. Post aged
7.4.1. Global post aged market, by end users, 2014 – 2020 (USD Million)
Chapter 8. Global Vaccine Market – Indication Segment Analysis
8.1. Global vaccine market: type overview
8.1.1. Global vaccine market revenue share, by indication, 2014 – 2020
8.2. Allergy
8.2.1. Global allergy market, by indication, 2014 – 2020 (USD Million)
8.3. Infectious disease
8.3.1. Global infectious disease market, by indication, 2014 – 2020 (USD Million)
8.4. Others
8.4.1. Global others market, by indication, 2014 – 2020 (USD Million)
Chapter 9. Global Vaccine market – Regional Segment Analysis
9.1. Global vaccine market: Regional overview
9.1.1. Global vaccine market revenue share by region, 2014 – 2020
9.2. North America
9.2.1. North America vaccine market revenue, by technology, 2014 – 2020 (USD Million)
9.2.2. North America vaccine market revenue, by type, 2014 – 2020 (USD Million)
9.2.3. North America vaccine market revenue, by end user, 2014 – 2020 (USD Million)
9.2.4. U.S.
9.2.4.1. U.S. vaccine market revenue, by technology, 2014 – 2020 (USD Million)
9.2.4.2. U.S. vaccine market revenue, by type, 2014 – 2020 (USD Million)
9.2.4.3. U.S. vaccine market revenue, by end user, 2014 – 2020 (USD Million)
9.3. Europe
9.3.1. Europe vaccine market revenue, by a technology, 2014 – 2020 (USD Million)
9.3.2. Europe vaccine market revenue, by type, 2014 – 2020 (USD Million)
9.3.3. Europe vaccine market revenue, by end user, 2014 – 2020 (USD Million)
9.3.4. Germany
9.3.4.1. Germany vaccine market revenue, by technology, 2014 – 2020 (USD Million)
9.3.4.2. Germany vaccine market revenue, by type, 2014 – 2020 (USD Million)
9.3.4.3. Germany vaccine market revenue, by end user, 2014 – 2020 (USD Million)
9.3.5. France
9.3.5.1. France vaccine market revenue, by technology, 2014 – 2020 (USD Million)
9.3.5.2. France vaccine market revenue, by type, 2014 – 2020 (USD Million)
9.3.5.3. France vaccine market revenue, by end user, 2014 – 2020 (USD Million)
9.3.6. UK
9.3.6.1. UK vaccine market revenue, by technology, 2014 – 2020 (USD Million)
9.3.6.2. UK vaccine market revenue, by type, 2014 – 2020 (USD Million)
9.3.6.3. UK vaccine market revenue, by end user, 2014 – 2020 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific vaccine market revenue, by technology, 2014 – 2020 (USD Million)
9.4.2. Asia Pacific vaccine market revenue, by type, 2014 – 2020 (USD Million)
9.4.3. Asia Pacific vaccine market revenue, by end user, 2014 – 2020 (USD Million)
9.4.4. China
9.4.4.1. China vaccine market revenue, by technology, 2014 – 2020 (USD Million)
9.4.4.2. China vaccine market revenue, by type, 2014 – 2020 (USD Million)
9.4.4.3. China vaccine market revenue, by end user, 2014 – 2020 (USD Million)
9.4.5. Japan
9.4.5.1. Japan vaccine market revenue, by technology, 2014 – 2020 (USD Million)
9.4.5.2. Japan vaccine market revenue, by type, 2014 – 2020 (USD Million)
9.4.5.3. Japan vaccine market revenue, by end user, 2014 – 2020 (USD Million)
9.4.6. India
9.4.6.1. India vaccine market revenue, by technology, 2014 – 2020 (USD Million)
9.4.6.2. India vaccine market revenue, by type, 2014 – 2020 (USD Million)
9.4.6.3. India vaccine market revenue, by end user, 2014 – 2020 (USD Million)
9.5. Latin America
9.5.1. Latin America vaccine market revenue, by technology, 2014 – 2020 (USD Million)
9.5.2. Latin America vaccine market revenue, by type, 2014 – 2020 (USD Million)
9.5.3. Latin America vaccine market revenue, by end user, 2014 – 2020 (USD Million)
9.5.4. Brazil
9.5.4.1. Brazil vaccine market revenue, by technology, 2014 – 2020 (USD Million)
9.5.4.2. Brazil vaccine market revenue, by type, 2014 – 2020 (USD Million)
9.5.4.3. Brazil vaccine market revenue, by end user, 2014 – 2020 (USD Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa vaccine market revenue, by technology, 2014 – 2020 (USD Million)
9.6.2. Middle East and Africa vaccine market revenue, by type, 2014 – 2020 (USD Million)
9.6.3. Middle East and Africa vaccine market revenue, by end user, 2014 – 2020 (USD Million)
Chapter 10. Company Profile
10.1. Pfizer
10.1.1. Overview
10.1.2. Financials
10.1.3. Product portfolio
10.1.4. Business strategy
10.1.5. Recent developments
10.2. CSL Limited
10.2.1. Overview
10.2.2. Financials
10.2.3. Product portfolio
10.2.4. Business strategy
10.2.5. Recent developments
10.3. GlaxoSmithKline plc
10.3.1. Overview
10.3.2. Financials
10.3.3. Product portfolio
10.3.4. Business strategy
10.3.5. Recent developments
10.4. MedImmune LLC
10.4.1. Overview
10.4.2. Financials
10.4.3. Product portfolio
10.4.4. Business strategy
10.4.5. Recent developments
10.5. Novartis AG
10.5.1. Overview
10.5.2. Financials
10.5.3. Product portfolio
10.5.4. Business strategy
10.5.5. Recent developments
10.6. Sanofi Pasteur
10.6.1. Overview
10.6.2. Financials
10.6.3. Product portfolio
10.6.4. Business strategy
10.6.5. Recent developments
10.7. Merck and Company
10.7.1. Overview
10.7.2. Financials
10.7.3. Product portfolio
10.7.4. Business strategy
10.7.5. Recent developments
10.8. Johnson and Johnson
10.8.1. Overview
10.8.2. Financials
10.8.3. Product portfolio
10.8.4. Business strategy
10.8.5. Recent developments
10.9. Emergent BioSolutions Inc
10.9.1. Overview
10.9.2. Financials
10.9.3. Product portfolio
10.9.4. Business strategy
10.9.5. Recent developments
List of Tables

1. Global vaccine market estimates and forecast, 2014 – 2020 (USD Million)
2. Global vaccine market, by region, 2014 – 2020 (USD Million)
3. Global vaccine market, by technology, 2014 – 2020 (USD Million)
4. Global vaccine market, by type, 2014 – 2020 (USD Million)
5. Global vaccine market, by end users, 2014 – 2020 (USD Million)
6. Global vaccine market, by indications, 2014 – 2020 (USD Million)
7. Vaccine – Key market driver analysis
8. Vaccine – Key market restraint analysis
9. North America vaccine market revenue, by technology, 2014 – 2020 (USD Million)
10. North America vaccine market revenue, by type, 2014 – 2020 (USD Million)
11. North America vaccine market revenue, by end users, 2014 – 2020 (USD Million)
12. U.S. vaccine market revenue, by technology, 2014 – 2020 (USD Million)
13. U.S. vaccine market revenue, by type, 2014 – 2020 (USD Million)
14. U.S. vaccine market revenue, by end users, 2014 – 2020 (USD Million)
15. Europe vaccine market revenue, by technology, 2014 – 2020 (USD Million)
16. Europe vaccine market revenue, by type, 2014 – 2020 (USD Million)
17. Europe vaccine market revenue, by end users, 2014 – 2020 (USD Million)
18. Germany vaccine market revenue, by technology, 2014 – 2020 (USD Million)
19. Germany vaccine market revenue, by type, 2014 – 2020 (USD Million)
20. Germany vaccine market revenue, by end users, 2014 – 2020 (USD Million)
21. France vaccine market revenue, by technology, 2014 – 2020 (USD Million)
22. France vaccine market revenue, by type, 2014 – 2020 (USD Million)
23. France vaccine market revenue, by end users, 2014 – 2020 (USD Million)
24. UK vaccine market revenue, by technology, 2014 – 2020 (USD Million)
25. UK vaccine market revenue, by type, 2014 – 2020 (USD Million)
26. UK vaccine market revenue, by end users, 2014 – 2020 (USD Million)
27. Asia Pacific vaccine market revenue, by technology, 2014 – 2020 (USD Million)
28. Asia Pacific vaccine market revenue, by type, 2014 – 2020 (USD Million)
29. Asia Pacific vaccine market revenue, by end users, 2014 – 2020 (USD Million)
30. China vaccine market revenue, by technology, 2014 – 2020 (USD Million)
31. China vaccine market revenue, by type, 2014 – 2020 (USD Million)
32. China vaccine market revenue, by end users, 2014 – 2020 (USD Million)
33. Japan vaccine market revenue, by technology, 2014 – 2020 (USD Million)
34. Japan vaccine market revenue, by type, 2014 – 2020 (USD Million)
35. Japan vaccine market revenue, by end users, 2014 – 2020 (USD Million)
36. India vaccine market revenue, by technology, 2014 – 2020 (USD Million)
37. India vaccine market revenue, by type, 2014 – 2020 (USD Million)
38. India vaccine market revenue, by end users, 2014 – 2020 (USD Million)
39. Latin America vaccine market revenue, by technology, 2014 – 2020 (USD Million)
40. Latin America vaccine market revenue, by type, 2014 – 2020 (USD Million)
41. Latin America vaccine market revenue, by end users, 2014 – 2020 (USD Million)
42. Brazil vaccine market revenue, by technology, 2014 – 2020 (USD Million)
43. Brazil vaccine market revenue, by type, 2014 – 2020 (USD Million)
44. Brazil vaccine market revenue, by end users, 2014 – 2020 (USD Million)
45. Middle East and Africa vaccine market revenue, by technology, 2014 – 2020 (USD Million)
46. Middle East and Africa vaccine market revenue, by type, 2014 – 2020 (USD Million)
47. Middle East and Africa vaccine market revenue, by end users, 2014 – 2020 (USD Million)

List of Figures

1. Vaccine market segmentation
2. Global vaccine market revenue, 2014 – 2020 (USD Million)
3. Vaccine: Market attractiveness analysis, by technology segment
4. Vaccine: Market attractiveness analysis, by type segment
5. Vaccine: Market attractiveness analysis, by end users segment
6. Vaccine: Market attractiveness analysis, by indication segment
7. Vaccine: Market attractiveness analysis, by regional segment
8. Global vaccine market revenue share by technology, 2014 – 2020
9. Global inactivated vaccines market, 2014 – 2020
10. Global subunit vaccines market, 2014 – 2020
11. Global conjugate vaccines market, 2014 – 2020
12. Global live attenuated vaccines market, 2014 – 2020
13. Global toxoid vaccines market, 2014 – 2020
14. Global others vaccines market, 2014 – 2020
15. Global vaccine market revenue share by type, 2014 – 2020
16. Global therapeutic vaccines market, 2014 – 2020
17. Global preventive vaccines market, 2014 – 2020
18. Global vaccine market revenue share by end users, 2014 – 2020
19. Global infants market, 2014 – 2020
20. Global early aged market, 2014 – 2020
21. Global post aged market, 2014 – 2020
22. Global vaccine market revenue share by indication, 2014 – 2020
23. Global allergy market, 2014 – 2020
24. Global infectious diseases market, 2014 – 2020
25. Global tumors market, 2014 – 2020
26. Global others market, 2014 – 2020
27. Global vaccine market revenue share by region, 2014 – 2020


* Indicates required field.

Your Name*

Your Email*

Telephone Number*

Name of company*

Country Name*

How can we help you?

Prove You are Human*

captcha
Enter Capcha Image Properly




Share this Post

Related Posts

Checking...

Ouch! There was a server error.
Retry »

Sending message...

Enquiry Form

Fill in the form below and we will be in touch soon

Create Account



Log In Your Account